Madrigal Pharmaceuticals (MDGL) PT Lowered to $190 at Oppenheimer
Tweet
Share
E-mailGet Alerts MDGL Hot Sheet
Price: $117.02 +0.37%
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 42
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 42
Trade Now!
Join SI Premium – FREE
Oppenheimer analyst Jay Olson lowered the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $190.00 (from $200.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Macquarie Downgrades Rengo Co Ltd. (3941:JP) to Neutral
- Standard Life Aberdeen Plc. (SLA:LN) (SLFPY) PT Raised to GBP3.76 at Goldman Sachs
- flatexDEGIRO AG (FTKn:GR) (FNNTF) PT Raised to EUR100 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
